Invention Grant
- Patent Title: Pyrrolopyridazines as potassium ion channel inhibitors
- Patent Title (中): 吡咯并哒嗪作为钾离子通道抑制剂
-
Application No.: US14772152Application Date: 2014-03-10
-
Publication No.: US09458164B2Publication Date: 2016-10-04
- Inventor: Heather Finlay , Ashok Kumar Adisechan , Prashantha Gunaga , John Lloyd , Srinivasu Pothukanuri
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Mary K. VanAtten
- International Application: PCT/US2014/022238 WO 20140310
- International Announcement: WO2014/143607 WO 20140918
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61K31/5025
Abstract:
A compound of formula (I) wherein A, R1, R3, and R24 are described herein. The compounds are useful as inhibitors of potassium channel function and in the treatment of arrhythmia, IKur-associated disorders, and other disorders mediated by ion channel function.
Public/Granted literature
- US20160016961A1 PYRROLOPYRIDAZINES AS POTASSIUM ION CHANNEL INHIBITORS Public/Granted day:2016-01-21
Information query
